Your browser doesn't support javascript.
loading
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes.
Santini, Valeria; Valcárcel, David; Platzbecker, Uwe; Komrokji, Rami S; Cleverly, Ann L; Lahn, Michael M; Janssen, Jan; Zhao, Yumin; Chiang, Alan; Giagounidis, Aristoteles; Guba, Susan C; Gueorguieva, Ivelina; Girvan, Allicia C; da Silva Ferreira, Mariana; Bhagat, Tushar D; Pradhan, Kith; Steidl, Ulrich; Sridharan, Ashwin; Will, Britta; Verma, Amit.
Afiliação
  • Santini V; MDS Unit, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy. amit.verma@einstein.yu.edu valeria.santini@unifi.it.
  • Valcárcel D; Department of Hematology, Vall d'Hebrón University Hospital, Barcelona, Spain.
  • Platzbecker U; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Cleverly AL; Eli Lilly and Company, Erl Wood, United Kingdom.
  • Lahn MM; Eli Lilly and Company, Indianapolis, Indiana.
  • Janssen J; Onkologische Gemeinschaftspraxis, Westerstede, Germany.
  • Zhao Y; Eli Lilly and Company, Indianapolis, Indiana.
  • Chiang A; Eli Lilly and Company, Indianapolis, Indiana.
  • Giagounidis A; Clinic for Hematology, Oncology and Palliative Care, Marienhospital, Düsseldorf, Germany.
  • Guba SC; Eli Lilly and Company, Indianapolis, Indiana.
  • Gueorguieva I; Eli Lilly and Company, Erl Wood, United Kingdom.
  • Girvan AC; Eli Lilly and Company, Indianapolis, Indiana.
  • da Silva Ferreira M; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Bhagat TD; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Pradhan K; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Steidl U; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Sridharan A; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Will B; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Verma A; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York. amit.verma@einstein.yu.edu valeria.santini@unifi.it.
Clin Cancer Res ; 25(23): 6976-6985, 2019 12 01.
Article em En | MEDLINE | ID: mdl-31481511
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Quinolinas / Síndromes Mielodisplásicas / Receptor do Fator de Crescimento Transformador beta Tipo I / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Quinolinas / Síndromes Mielodisplásicas / Receptor do Fator de Crescimento Transformador beta Tipo I / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article